Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 295

1.

Glycine protects partial liver grafts from Kupffer cell-dependent ischemia-reperfusion injury without negative effect on regeneration.

Al-Saeedi M, Liang R, Schultze DP, Nickkholgh A, Herr I, Zorn M, Schemmer P.

Amino Acids. 2019 Apr 2. doi: 10.1007/s00726-019-02722-5. [Epub ahead of print]

PMID:
30941574
2.

Semi-automated computed tomography Volumetry can predict hemihepatectomy specimens' volumes in patients with hepatic malignancy.

Mayer P, Grözinger M, Mokry T, Schemmer P, Waldburger N, Kauczor HU, Klauss M, Sommer CM.

BMC Med Imaging. 2019 Feb 26;19(1):20. doi: 10.1186/s12880-019-0309-5.

3.

Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool.

Kahn J, Schemmer P.

Visc Med. 2018 Dec;34(6):444-448. doi: 10.1159/000493889. Epub 2018 Oct 30. Review.

PMID:
30675491
4.

N-acetylcysteine protects hepatocytes from hypoxia-related cell injury.

Heil J, Schultze D, Schemmer P, Bruns H.

Clin Exp Hepatol. 2018 Dec;4(4):260-266. doi: 10.5114/ceh.2018.80128. Epub 2018 Dec 3.

5.

Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression.

Apostolidis L, Pfeiffenberger J, Gotthardt D, Radeleff B, Mehrabi A, Schemmer P, Jäger D, Schirmacher P, Stremmel W, Schulze-Bergkamen H, Springfeld C, Weiss KH.

Gastrointest Tumors. 2018 Sep;5(1-2):38-46. doi: 10.1159/000487635. Epub 2018 Apr 11.

6.

Impact of Melatonin in Solid Organ Transplantation-Is It Time for Clinical Trials? A Comprehensive Review.

Stiegler P, Bausys A, Leber B, Strupas K, Schemmer P.

Int J Mol Sci. 2018 Nov 8;19(11). pii: E3509. doi: 10.3390/ijms19113509. Review.

7.

2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation.

Adam R, Karam V, Cailliez V, O Grady JG, Mirza D, Cherqui D, Klempnauer J, Salizzoni M, Pratschke J, Jamieson N, Hidalgo E, Paul A, Andujar RL, Lerut J, Fisher L, Boudjema K, Fondevila C, Soubrane O, Bachellier P, Pinna AD, Berlakovich G, Bennet W, Pinzani M, Schemmer P, Zieniewicz K, Romero CJ, De Simone P, Ericzon BG, Schneeberger S, Wigmore SJ, Prous JF, Colledan M, Porte RJ, Yilmaz S, Azoulay D, Pirenne J, Line PD, Trunecka P, Navarro F, Lopez AV, De Carlis L, Pena SR, Kochs E, Duvoux C; all the other 126 contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA).

Transpl Int. 2018 Dec;31(12):1293-1317. doi: 10.1111/tri.13358.

PMID:
30259574
8.

Donor Dopamine Does Not Affect Liver Graft Survival: Evidence of Safety From a Randomized Controlled Trial.

Benck U, Jung M, Krüger B, Grimm A, Weiss C, Yard BA, Lehner F, Kiessling A, Fischer L, Gallinat A, Kleespies A, Lorf T, Sucher R, Mönch C, Scherer MN, Rahmel A, Schemmer P, Krämer BK, Schnuelle P.

Liver Transpl. 2018 Oct;24(10):1336-1345. doi: 10.1002/lt.25301.

PMID:
30102825
9.

Glycine Protects the Liver from Reperfusion Injury following Pneumoperitoneum.

Al-Saeedi M, Nickkholgh A, Schultze D, Flechtenmacher C, Zorn M, Liang R, Gutt CN, Schemmer P.

Eur Surg Res. 2018;59(1-2):91-99. doi: 10.1159/000490309. Epub 2018 Jul 20.

PMID:
30032156
10.

Evaluation of Graft Effluent High Mobility Group Box-1 (HMGB-1) for Prediction of Outcome After Liver Transplantation.

Houben P, Hohenberger R, Yamanaka K, Büchler MW, Schemmer P.

Ann Transplant. 2018 Jul 13;23:475-480. doi: 10.12659/AOT.909165.

11.

Comprehensive Review on Custodiol-N (HTK-N) and its Molecular Side of Action for Organ Preservation.

Kahn J, Schemmer P.

Curr Pharm Biotechnol. 2017;18(15):1237-1248. doi: 10.2174/1389201019666180409165154. Review.

PMID:
29637857
12.

Robot-Assisted Transplant Surgery - Vision or Reality? A Comprehensive Review.

Stiegler P, Schemmer P.

Visc Med. 2018 Feb;34(1):24-30. doi: 10.1159/000485686. Epub 2018 Feb 7. Review.

13.

Both sarcopenia and frailty determine suitability of patients for liver transplantation-A systematic review and meta-analysis of the literature.

Kahn J, Wagner D, Homfeld N, Müller H, Kniepeiss D, Schemmer P.

Clin Transplant. 2018 Apr;32(4):e13226. doi: 10.1111/ctr.13226. Epub 2018 Mar 23. Review.

PMID:
29478305
14.

HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.

Mutz P, Metz P, Lempp FA, Bender S, Qu B, Schöneweis K, Seitz S, Tu T, Restuccia A, Frankish J, Dächert C, Schusser B, Koschny R, Polychronidis G, Schemmer P, Hoffmann K, Baumert TF, Binder M, Urban S, Bartenschlager R.

Gastroenterology. 2018 May;154(6):1791-1804.e22. doi: 10.1053/j.gastro.2018.01.044. Epub 2018 Feb 1.

15.

Extended Pancreas Donor Program-The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years.

Proneth A, Schnitzbauer AA, Schenker P, Wunsch A, Rauchfuss F, Arbogast H, Manekeller S, Nadalin S, Heise M, Ströhlein MA, Banas B, Schemmer P, Becker T, Bechstein WO, Pascher A, Viebahn R, Geissler EK, Schlitt HJ, Farkas SA.

Transplantation. 2018 Aug;102(8):1330-1337. doi: 10.1097/TP.0000000000002122.

PMID:
29406443
16.

Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure.

Al-Saeedi M, Steinebrunner N, Kudsi H, Halama N, Mogler C, Büchler MW, Krammer PH, Schemmer P, Müller M.

Cell Death Dis. 2018 Jan 26;9(2):132. doi: 10.1038/s41419-017-0150-0.

17.

De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells.

Görtz M, Galli U, Longerich T, Zöller M, Erb U, Schemmer P.

Oncol Rep. 2017 Nov;38(5):2697-2704. doi: 10.3892/or.2017.5980. Epub 2017 Sep 20.

18.

Are our endoscopy patients at risk for pyogenic liver abscess?

Cerwenka H, Schemmer P.

World J Gastroenterol. 2017 Aug 14;23(30):5457-5459. doi: 10.3748/wjg.v23.i30.5457.

19.

Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.

Račkauskas R, Zhou D, Ūselis S, Strupas K, Herr I, Schemmer P.

Oncol Rep. 2017 Jun;37(6):3660-3666. doi: 10.3892/or.2017.5622. Epub 2017 May 3.

PMID:
28498473
20.

Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation.

Wannhoff A, Rauber C, Friedrich K, Rupp C, Stremmel W, Weiss KH, Schemmer P, Gotthardt DN.

United European Gastroenterol J. 2017 Feb;5(1):86-93. doi: 10.1177/2050640616650060. Epub 2016 Jul 8.

Supplemental Content

Loading ...
Support Center